Insulet Corporation (NASDAQ: PODD) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses

Lead Plaintiff Deadline: August 31, 2026

Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the "Class Period").

The lawsuit alleges that Insulet made materially false or misleading statements regarding its manufacturing controls and the safety and reliability of its insulin delivery products.

Investors who suffered losses during the Class Period may have legal rights and should be aware of the August 31, 2026 deadline to seek appointment as lead plaintiff.